Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اكتيبولاغيت هاسل, اول سيفيد المجرين كنوت, غوران ديوك ديوكر بيرنت, كريستر ستراند لوند غيرتfiledCriticalاكتيبولاغيت هاسل
Priority to JO19891594ApriorityCriticalpatent/JO1594B1/en
Application grantedgrantedCritical
Publication of JO1594B1publicationCriticalpatent/JO1594B1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
A compounds of the formula And when appropriate in the form of a racemic mixture or in the form of a steroisomeric component and the pharmaceutically acceptable salts thereof, in which formula N is an interger 0.1. or 2 Y is (ch2)m, CHOH, CHOCH3, CHNHR Or CHF, M is an interger 0 or 1 and R is hydrogen , methyl or ethyl Z is hydrogen or a saturated or unsaturated , straight or branched alkyl group containing 1-3 carbon atoms A is group Where Ra is a straight or brached hydroxyalkyl or an alkyl Group containing 1-5 carbon atoms and optionally substituted by one or more fluoro atoms Rc is a saturated or unsaturated , straight or branched alkyl group containing 1-4 carbon atoms and optionally substituted by one or more fluoro atoms Ra’ is the same as Ra and independently of Ra Ra is the same as Ra and independently of Ra P is an interger 0.1 or 2 S is an integer 2.3.4.5 Useful for the treatment of cardiac arrhythmia, pharmaceutical compostions containing such compounds as active ingredients, processes for preparation of such components as well as intermediates for their preparation,
Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
SELECTIVE, BIOLOGICALLY ACTIVE 7-OXO-PROSTACYCLIN-DERIVATED SAMT FRAMSTAELLNINGSFOERFARANDE FOER DESSA SAMT DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION.